Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
George Simeon, MPH
CEO
Curevo Inc.
Disclosure(s): Curevo Inc.: Board Member, salary, Stocks/Bonds (Private Company)
Poster(s):
(P-597) Amezosvatein Demonstrates Non-Inferior Immunogenicity and Superior Tolerability Head-to-Head vs Shingrix in a Phase 2 Herpes Zoster Vaccine Trial
Thursday, October 17, 2024
12:15 PM – 1:30 PM
US PT